Combination therapy in myopia: Does one plus one equal two?
Date: 22/07/2025 ()
Venue: Online, AUSTRALIA
Provider: ZEISS
Contact: Elmarie Pretorius, [E] elmarie.pretorius@zeiss.com, [P] 0418209350
Activity Outline
Myopia has become a significant global health concern over the past decade, affecting quality of life and increasing risks with higher levels. This webinar addresses the growing prevalence of myopia worldwide, with a focus on its impact in Australia. Participants will gain insights into the individual and societal burdens of myopia, exploring strategies for effective management and standard care practices.
Moderated by Professor Padmaja Sankaridurg, the webinar features presentations from Dr. Tim Fricke, Dr. Li Lian Foo, and Mr. Philip Cheng. These experts will discuss evidence-based management strategies, emphasizing combination therapies as a potential standard of care, especially for high-risk populations.
Key topics include:
• The prevalence of myopia and its impact on quality of life.
• Risks associated with myopia and their correlation with progression.
• Effective management strategies in the Australian context.
• Identification and management of higher-risk populations.
Presenters will share real-world case reports to illustrate successful management plan implementation, evaluation of effectiveness, and alternative options if myopia progression minimization is unsatisfactory. This practical approach aims to equip attendees with actionable insights for clinical practice.
The webinar concludes with an interactive discussion, allowing attendees to engage with the expert panel, ask questions, and resolve challenges in their practice. This session promises to enhance understanding and application of myopia management strategies, contributing to improved patient care and outcomes.
Designed for optometrists and eye care professionals, this webinar supports continuous professional development in myopia management.
Learning Objectives
- Know the impact myopia is having globally and in Australia
- Know the impact myopia has on a person
- Discuss the management strategies are available to impact myopia progression
- Describe when a myopia management plan should be implemented
- Discuss which strategies are effective in combination
- Describe when these strategies can be practically introduced in practice
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Interactive Case Studies |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Should we care about myopia in our region |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.25 |
| Name |
|---|
| Will combination therapy become the standard of care in high risk environments |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.25 |
| Name |
|---|
| Role for combination therapy in our region |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.25 |